LetsGetChecked Acquires BioIQ
November 16, 2021
LetsGetChecked has acquired BioIQ, an analytics-driven population health and diagnostics company, with BioIQ operating as a wholly owned subsidiary. The deal expands LetsGetChecked’s at-home diagnostics, telehealth and pharmacy capabilities and broadens its reach into health plan, employer and public-sector markets.
- Buyers
- LetsGetChecked
- Targets
- BioIQ
- Industry
- Healthcare Services
- Location
- Georgia, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Providence Equity Partners to Acquire Majority Stake in CheckedUp
August 18, 2026
Media & Entertainment
Providence Equity Partners has agreed to acquire a majority stake in CheckedUp, a specialty point-of-care education and engagement platform. Varsity Healthcare Partners will join as a strategic minority investor, with co-founders Dr. Richard Awdeh and Mark Awdeh continuing to lead the company.
-
LetsGetChecked Acquires Truepill
October 1, 2024
Healthcare Services
LetsGetChecked has completed the acquisition of Truepill, a digital pharmacy platform, to integrate pharmacy technology and medication fulfillment into its at-home healthcare solutions. The deal creates a combined offering that spans testing, virtual care, and prescription delivery to support a full lifecycle of care for employers, health plans, providers, and consumer patients.
-
Ginkgo Bioworks Acquires Proof Diagnostics
February 28, 2024
Biotechnology
Ginkgo Bioworks has acquired Proof Diagnostics to integrate Proof's OMEGA nuclease libraries and portable diagnostic technologies into Ginkgo’s gene therapy and genetic medicines platform. The deal expands Ginkgo’s gene editing toolkit and diagnostic capabilities to better serve customers developing programmable medicines and rapid detection systems.
-
LetsGetChecked Acquires Veritas Genetics and Veritas Intercontinental
March 29, 2022
Healthcare Services
LetsGetChecked announced it will acquire Veritas Genetics Inc. and Veritas Intercontinental to integrate whole genome sequencing and expanded genomic services into its at‑home diagnostics and virtual care platform. The deal adds capabilities across prenatal, predictive medicine, pharmacogenomics and cancer screening and positions LetsGetChecked to expand genomic offerings internationally.
-
Rockbridge Growth Equity Invests in CheckedUp
January 5, 2022
Healthcare Services
Detroit-based Rockbridge Growth Equity made a growth investment in CheckedUp, a physician-founded digital point-of-care patient education and digital out-of-home network, to fund technology innovation, expand the company's reach, and support scaling initiatives. Terms were not disclosed; senior debt was provided by Fifth Third Bank and legal advisors on the deal included Covington Associates and Greenberg Traurig for CheckedUp and Honigman for Rockbridge.
-
BioCheck, Inc. Acquires DRG International, Inc.
August 18, 2021
Medical Devices
BioCheck, Inc. has acquired DRG International, Inc., a manufacturer of clinical diagnostic ELISAs and the DRG:HYBRiD-XL automated analyzer. The deal combines BioCheck's chemiluminescent assay development and automation platform with DRG's R&D, manufacturing and global distribution network to accelerate development and global scale-up of advanced clinical and research diagnostic tests.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.